Clinical Drug Trials

Released by human immune systems, cytokines are known to be effective against COVID-19. Unfortunately, patients infected with SARS-CoV-2 are unable to produce them. But these doctors found a solution. #IndiaFightsCorona

Used to treat rheumatoid arthritis, #Tocilizumab got the green light because of its ability to lower the inflammatory overreaction of the human immune system, which leads to death in infected patients.